Rakovina Therapeutics Inc announced a non-brokered Private placement of 15,000,000 shares at issue price CAD 0.10 per Unit for gross proceeds CAD 1,500,000 on May 23, 2024. Each Unit will be comprised of one common share and one share purchase warrant at a purchase price of CAD 0.20 for a period of three years after the closing date of the Offering. The Units will be sold on a non-brokered ?private placement?

basis in accordance with applicable Canadian securities laws and under applicable exemptions from prospectus and registration requirements and the securities will be subject to resale restrictions for a period of four months plus one day from the date of issue. The transaction includes lead orders totaling approximately CAD 1.25 million from two new investors.